Effect | None |
Trial Design | Double blind |
Trial Length | 6+ Months |
Number of Subjects | 177 |
Sex | Female |
Age Range | 45-64 |
Body Types | Overweight |
43.5mg of red clover isoflavones daily for one year has failed to significantly improve cardiovascular risk factors, and when controlling for the ApoE genotype there was a stronger trend for inprovement that still failed to reach statistical significance.